• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中年乳腺癌幸存者的低骨密度:患病率及相关因素

Low Bone Mineral Density in Middle-Aged Breast Cancer Survivors: Prevalence and Associated Factors.

作者信息

Conde Délio Marques, Costa-Paiva Lúcia, Martinez Edson Zangiacomi, Mendes Pinto-Neto Aarão

机构信息

Breast Service, Hospital for Maternal and Child Healthcare, Goiânia, Ribeirão Preto, Brazil.

出版信息

Breast Care (Basel). 2012 Apr;7(2):121-125. doi: 10.1159/000337763. Epub 2012 Apr 23.

DOI:10.1159/000337763
PMID:22740798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3376365/
Abstract

BACKGROUND

The aim of this study was to investigate the prevalence of low bone mineral density (BMD) and associated factors in middle-aged breast cancer survivors (BCS). PATIENTS AND METHODS: A cross-sectional study was conducted with 70 BCS of 45-65 years of age undergoing complete oncology treatment. Logistic regression models were used to identify factors associated with low BMD (osteopenia and osteoporosis taken together as a single group). RESULTS: The mean age of participants was 53.2 ± 5.9 years. BMD was low at the femoral neck in 28.6% of patients and at the lumbar spine in 45.7%. Body mass index ≤ 30 kg/m(2) (adjusted odds ratio (OR) 3.43; 95% confidence interval (CI) 1.0-11.3) and postmenopausal status (OR adjusted 20.42; 95% CI 2.0-201.2) were associated with low BMD at the lumbar spine. Femoral neck measurements, age > 50 years (OR 3.41; 95% CI 1.0-11.6), and time since diagnosis > 50 months (OR adjusted 3.34; 95% CI 1.0-11.3) increased the likelihood of low BMD. CONCLUSION: These findings show that low BMD is common in middle-aged BCS. Factors were identified that may affect BMD in BCS and should be considered when implementing strategies to minimize bone loss in middle-aged women with breast cancer.

摘要

背景

本研究旨在调查中年乳腺癌幸存者(BCS)中低骨密度(BMD)的患病率及相关因素。

患者与方法

对70名年龄在45 - 65岁且已完成肿瘤治疗的BCS进行了一项横断面研究。采用逻辑回归模型来确定与低骨密度(将骨质减少和骨质疏松合并为一组)相关的因素。

结果

参与者的平均年龄为53.2±5.9岁。28.6%的患者股骨颈骨密度低,45.7%的患者腰椎骨密度低。体重指数≤30kg/m²(调整后的优势比(OR)为3.43;95%置信区间(CI)为1.0 - 11.3)和绝经后状态(调整后的OR为20.42;95%CI为2.0 - 201.2)与腰椎低骨密度相关。股骨颈测量值、年龄>50岁(OR为3.41;95%CI为1.0 - 11.6)以及诊断后时间>50个月(调整后的OR为3.34;95%CI为1.0 - 11.3)增加了低骨密度的可能性。

结论

这些发现表明低骨密度在中年BCS中很常见。已确定了可能影响BCS骨密度的因素,在实施策略以尽量减少中年乳腺癌女性骨质流失时应予以考虑。

相似文献

1
Low Bone Mineral Density in Middle-Aged Breast Cancer Survivors: Prevalence and Associated Factors.中年乳腺癌幸存者的低骨密度:患病率及相关因素
Breast Care (Basel). 2012 Apr;7(2):121-125. doi: 10.1159/000337763. Epub 2012 Apr 23.
2
Bone mineral density in postmenopausal women with and without breast cancer.患有和未患乳腺癌的绝经后女性的骨矿物质密度
Rev Assoc Med Bras (1992). 2012 Nov-Dec;58(6):673-8.
3
Low bone mineral density is associated with breast cancer in postmenopausal women: a case-control study.低骨矿物质密度与绝经后女性乳腺癌相关:一项病例对照研究。
Climacteric. 2017 Oct;20(5):491-497. doi: 10.1080/13697137.2017.1329290. Epub 2017 Jun 1.
4
[Prevalence of low bone mineral density in postmenopausal breast cancer survivors].[绝经后乳腺癌幸存者中低骨密度的患病率]
Rev Bras Ginecol Obstet. 2015 Jan;37(1):30-5. doi: 10.1590/SO100-720320140005134.
5
Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.科威特最大省份的绝经后科威特女性居民中低骨量的流行情况。
Arch Osteoporos. 2012;7:147-53. doi: 10.1007/s11657-012-0092-1. Epub 2012 Sep 1.
6
Screening for osteopenia and osteoporosis: selection by body composition.骨质减少和骨质疏松症的筛查:基于身体成分的选择
Osteoporos Int. 1996;6(2):120-6. doi: 10.1007/BF01623934.
7
Longitudinal study on physical fitness parameters influencing bone mineral density reduction in middle-aged and elderly women: bone mineral density in the lumbar spine, femoral neck, and femur.影响中老年女性骨密度降低的体能参数纵向研究:腰椎、股骨颈和股骨的骨密度
Hiroshima J Med Sci. 2012 Jun;61(2):23-8.
8
Analysis of the Increase in Bone Mineral Density After Surgical Treatment of Primary Hyperparathyroidism.原发性甲状旁腺功能亢进症手术后骨密度增加的分析。
J Clin Densitom. 2019 Apr-Jun;22(2):171-178. doi: 10.1016/j.jocd.2018.11.001. Epub 2018 Nov 9.
9
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.安大略省双能X线吸收法骨密度测定的应用:基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.
10
Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis?口服双膦酸盐类药物对改善患有骨质减少或骨质疏松症的乳腺癌幸存者的腰椎骨密度是否有效?
J Obstet Gynaecol Can. 2005 Aug;27(8):759-64. doi: 10.1016/s1701-2163(16)30727-7.

引用本文的文献

1
Body Composition, Metabolism, and Inflammation in Breast Cancer Survivors and Healthy Age-matched Controls: A Cross-Sectional Analysis.乳腺癌幸存者与年龄匹配的健康对照者的身体成分、代谢及炎症:一项横断面分析。
Int J Exerc Sci. 2020 Aug 1;13(3):1108-1119. doi: 10.70252/LSJI9519. eCollection 2020.
2
High Bone Mineral Density of the Lumbar Spine Is Positively Associated with Breast Cancer.腰椎骨矿物质密度高与乳腺癌呈正相关。
Biomed Res Int. 2019 May 23;2019:8010356. doi: 10.1155/2019/8010356. eCollection 2019.
3
Combined aerobic and resistance training improves bone health of female cancer survivors.有氧训练和抗阻训练相结合可改善女性癌症幸存者的骨骼健康。
Bone Rep. 2016 Sep 21;5:274-279. doi: 10.1016/j.bonr.2016.09.003. eCollection 2016 Dec.
4
Soy isoflavone intake and bone mineral density in breast cancer survivors.乳腺癌幸存者的大豆异黄酮摄入量与骨密度
Cancer Causes Control. 2015 Apr;26(4):571-80. doi: 10.1007/s10552-015-0534-3. Epub 2015 Feb 17.
5
Mind the gaps: missed opportunities to promote bone health among cancer survivors.
Support Care Cancer. 2015 Mar;23(3):611-4. doi: 10.1007/s00520-014-2497-4. Epub 2014 Nov 5.
6
Bone Metastasis in Breast Cancer.乳腺癌的骨转移
Breast Care (Basel). 2012 Apr;7(2):90-91. doi: 10.1159/000338708. Epub 2012 Apr 24.

本文引用的文献

1
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
2
Executive summary: Stages of Reproductive Aging Workshop (STRAW) Park City, Utah, July, 2001.执行摘要:生殖衰老阶段研讨会(STRAW),犹他州帕克城,2001年7月。
Menopause. 2001 Nov-Dec;8(6):402-7. doi: 10.1097/00042192-200111000-00004.
3
Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency?绝经前早期乳腺癌女性辅助化疗期间骨密度丢失:是否与雌激素缺乏有关?
Breast Cancer Res Treat. 2010 Oct;123(3):805-14. doi: 10.1007/s10549-010-0899-7. Epub 2010 Aug 5.
4
Assessment of risk factors for low bone mineral density in Brazilian postmenopausal women.评估巴西绝经后妇女低骨密度的危险因素。
Climacteric. 2011 Apr;14(2):220-7. doi: 10.3109/13697137.2010.490969. Epub 2010 Jul 19.
5
Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause.绝经后过渡期卵泡刺激素分期与末次月经周围时间相关的骨丢失量。
J Clin Endocrinol Metab. 2010 May;95(5):2155-62. doi: 10.1210/jc.2009-0659. Epub 2010 Mar 9.
6
Relationships between serum adiponectin, leptin concentrations and bone mineral density, and bone biochemical markers in Chinese women.中国女性血清脂联素、瘦素浓度与骨密度及骨生化标志物的关系。
Clin Chim Acta. 2010 May 2;411(9-10):771-5. doi: 10.1016/j.cca.2010.02.064. Epub 2010 Feb 23.
7
Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.绝经后妇女骨质疏松症的管理:北美绝经学会 2010 年立场声明。
Menopause. 2010 Jan-Feb;17(1):25-54; quiz 55-6. doi: 10.1097/gme.0b013e3181c617e6.
8
Minireview: osteoprotective action of estrogens is mediated by osteoclastic estrogen receptor-alpha.综述:雌激素的骨保护作用由破骨细胞雌激素受体α介导。
Mol Endocrinol. 2010 May;24(5):877-85. doi: 10.1210/me.2009-0238. Epub 2009 Nov 12.
9
Bone Health and Falls: Fracture Risk in Breast Cancer Survivors With Chemotherapy-Induced Amenorrhea.骨骼健康与跌倒:化疗所致闭经的乳腺癌幸存者的骨折风险
Oncol Nurs Forum. 2009 May 1;36(3):315-325. doi: 10.1188/09.ONF.315-325.
10
Secondary causes of low bone mass in patients with breast cancer: a need for greater vigilance.乳腺癌患者低骨量的继发原因:需要提高警惕。
J Clin Oncol. 2009 Aug 1;27(22):3605-10. doi: 10.1200/JCO.2008.20.2549. Epub 2009 Jun 22.